TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
KR |
Intrinsic Value
The intrinsic value of TiumBio Co Ltd (321550) under the Base Case is 11 981.96 KRW per share. Compared with the current market price of 4 215 KRW, the stock appears Undervalued by 65% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -141% last year to -100% by 2031. Revenue grows about 29% a year over the next five years, less than half its five-year pace of 64%. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What TiumBio Does
TiumBio is a South Korean biotech company that develops medicines for rare and hard-to-treat diseases, with a strong focus on blood disorders such as hemophilia. It does not run a broad consumer business; instead, it works in drug research, preclinical and clinical development, and the preparation of new treatments for later approval and sale.
- Headquarters
- Korea KR
- IPO date
- Nov 22, 2019
Earnings Waterfall
TiumBio Co Ltd
The intrinsic value for TiumBio Co Ltd (321550) under the Base Case is 11 981.96 KRW.
Compared with the current market price of 4 215 KRW, the stock appears Undervalued by 65% .